Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7.2% year on year to $142 million. On the other hand, next ...
Exponent Inc. reported its second-quarter 2025 earnings, revealing a slight increase in revenue, but a decline in stock price during aftermarket trading. The company posted earnings per share (EPS) of ...
Exponent is a business that we have admired from the sidelines for a while, and we finally saw an opportunity to initiate a position at an attractive price due to a rare pause in annual growth. No ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback